Risk of Sudden Death in Sick Sinus Syndrome

Understanding the Risk Profile

The European Society of Cardiology suggests that sick sinus syndrome carries a relatively low risk of sudden cardiac death compared to other cardiac arrhythmias, with sudden death occurring primarily in patients who have coexisting left ventricular dysfunction rather than from the sinus node disease itself 1, 2
Bradyarrhythmias, including sick sinus syndrome, account for approximately 20% of all documented sudden cardiac deaths, according to the European Heart Journal 2, 3
The presence of structural heart disease, particularly left ventricular dysfunction, is the most critical determinant of sudden death risk, as stated by the European Heart Journal 1, 2, 5
When sudden cardiac death occurs in sick sinus syndrome patients, it mainly affects those with left ventricular dysfunction, as reported by the European Heart Journal 1, 2, 3

The American Heart Association recommends that permanent atrial or dual-chamber pacing relieves symptoms and improves quality of life, reduces morbidity and the incidence of atrial fibrillation, but the effect on survival is not known, as stated by the European Heart Journal 1, 2, 3, 6
The European Society of Cardiology indicates that pacemaker implantation is indicated when bradyarrhythmia has been demonstrated to account for syncope, and physiological pacing is superior to VVI pacing, as reported by the European Heart Journal and Praxis Medical Insights 6
Despite adequate pacing, syncope recurs in approximately 20% of patients during long-term follow-up due to associated vasodepressor reflex mechanisms, as stated by the European Heart Journal and Praxis Medical Insights 7, 6

The European Heart Journal notes that very few parameters are available for evaluating sudden cardiac death risk in patients with sinus node dysfunction, and electrocardiographic indexes correlate poorly with prognosis 1, 2, 3
Systematic evaluation of the association between sick sinus syndrome and sudden cardiac death is lacking, as reported by the European Heart Journal 1, 2
Implantable loop recorders may contribute to improved risk stratification, though evidence remains limited, as stated by the European Heart Journal 1, 2, 3